Overview and Scope
Sarcoma drugs are medication that are used to treat sarcoma. Sarcoma is a type of cancer that appears in connective tissues such as fat, muscle, blood vessels, and nerves as well as in bones. They target abnormal cells either by killing them directly or preventing them from growing and multiplying.
Sizing and Forecast
The sarcoma drugs market size has grown strongly in recent years. It will grow from $1.28 billion in 2023 to $1.39 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to healthcare infrastructure, treatment guidelines, patient advocacy groups, improved diagnosis methods, increased disease awareness.
The sarcoma drugs market size is expected to see strong growth in the next few years. It will grow to $1.97 billion in 2028 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to demand for novel therapies, healthcare investment, precision medicine, clinical trials and discoveries, research and development. Major trends in the forecast period include immunotherapy advancements, combination therapies, early diagnosis initiatives, biomarker research, patient-centric approach.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/sarcoma-drugs-global-market-report
Segmentation & Regional Insights
The sarcoma drugs market covered in this report is segmented –
1) By Treatment Type: Chemotherapy, Targeted Therapy
2) By Disease Indication: Malignant Bone Tumors, Soft Tissue Sarcomaz
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
North America was the largest region in the sarcoma drugs market in 2023. The regions covered in the sarcoma drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10571&type=smp
Major Driver Impacting Market Growth
The rising cases of soft tissue sarcoma is expected to propel the sarcoma drugs market going forward. Soft tissue sarcoma is a cancer that start in the soft tissues of the body such as muscles, fat, tendons, lymph and nerves. Sarcoma drugs are used in the healthcare industry for the treatment of bone and soft tissue sarcoma by attacking cancer cells and dividing the cells. For instance, in January 2023, according to a report published by American Cancer Society, a US-based cancer fighting organization, in the US about 13,400 new soft tissue sarcomas will be diagnosed and around 5140 people are expected to die of soft tissue sarcomas in 2023.Therefore, the rising cases of soft tissue sarcoma is driving the growth of the sarcoma drugs market.
Key Industry Players
Major companies operating in the sarcoma drugs market report are Amgen Inc., Bayer AG, Eisai Co. Ltd., Eli Lilly and Company, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Novartis AG, Pfizer Inc., AgonOX Inc., Daiichi Sankyo Company Limited, Merck & Co. Inc., Abbott Laboratories, AbbVie Inc., Amneal Pharmaceuticals LLC, Pharma Mar SA, Bristol-Myers Squibb Company, Fresenius Kabi AG, Ipsen SA, Radiopharm Theranostics, Baxter Healthcare Corporation, Akeso Biopharma, AstraZeneca plc, BeiGene Ltd., Bausch Health Companies Inc., Celgene Corporation, Shenzhen Chipscreen Biosciences Co. Ltd., Teva Pharmaceuticals Industries Ltd., Monopar Therapeutics Inc., Incyte Corporation, Sanofi SA, Takeda Pharmaceutical Company Limited, Roche Holding AG
The sarcoma drugs market report table of contents includes:
1. Executive Summary
2. Sarcoma Drugs Market Characteristics
3. Sarcoma Drugs Market Trends And Strategies
4. Sarcoma Drugs Market – Macro Economic Scenario
5. Global Sarcoma Drugs Market Size and Growth
.
.
.
31. Global Sarcoma Drugs Market Competitive Benchmarking
32. Global Sarcoma Drugs Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Sarcoma Drugs Market
34. Sarcoma Drugs Market Future Outlook and Potential Analysis
35. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
